Australia's Incannex Healthcare hits 6-1/2-year high on positive studies of its drug

American Cannabis

23/11/2020 04:58

** Shares of Incannex Healthcare  IHL.AX  rise as much as
21.7% to A$0.14, their highest since March 19, 2014
    ** The medicinal cannabis co reports positive results in
pre-clinical studies of its drug to potentially treat Sepsis
Associated Acute Respiratory Distress Syndrome (SAARDS) 
 urn:newsml:reuters.com:*:nGLF4vBLFL
    ** Co says SAARDS is a leading cause of mortality in
patients with COVID-19
    ** Stock posts its biggest intraday pct gain since July 17 
    ** More than 10.7 mln shares change hands, compared with the
30-day average volume of about 4.7 mln shares 
    ** Stock up 85.5% this year, as of last close 

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com;))